期刊文献+

消异汤抑制大鼠子宫内膜异位症血管内皮生长因子形成的研究 被引量:2

Study on Inhibiting Growth of Vascular Endothelial Growth Factor in Endometriosis Rats by Xiaoyi Tang Decoction
下载PDF
导出
摘要 目的:观察消异汤对大鼠子宫内膜异位症模型血管内皮生长因子(Vascular Endothelial Growth Factor,VEGF)形成的影响。方法:采用自体移植法建立子宫内膜异位症大鼠模型,将40只大鼠随机分为模型组、炔诺酮组、中药低剂量组、中药高剂量组,干预21 d后免疫组织化学SP法观察VEGF在大鼠异位内膜组织中的表达。结果:与模型组大鼠比较,余各组异位子宫内膜体积和VEGF(P<0.05)的表达明显降低。结论:消异汤可抑制模型大鼠异位内膜的生长与血管生成,这可能是其治疗子宫内膜异位症的作用机制之一。 Objective: Observing the effect of Xiaoyi tang Decoction on the growth of vascular endothelial growth factor (VEGF) in endometriosis model rats. Methods: The rat model of endometriosis was established by autologous transplantation. 40 rats were randomly divided into the model group, levonorgestrel group, low dose and high dose group of Chinese medicine. After 21 days intervention, observing the expression of VEGF in eetopic endometrium of rats by immunohistochemistry SP method. Results: Compared with the model group, the ectopic endometrial volume and the expression of VEGF is significantly lower in other groups ( P 〈 0. 05). Conclu- sion : Xiaoyi tang can inhibit the angiogenesis and growth of ectopic endometrium in rats, which may be one of the mechanisms of the Endometriosis treatment.
作者 郑燕 李雨璘 陈鲜 李宇轩 罗晓红 Zheng Yan;Li Yulin;Chen Xian;Li Yuxuan;Luo Xiaohong(Gynecology Section, the 2^nd College of Clinic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 610041, China;Pathology Section, Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China)
出处 《成都中医药大学学报》 2018年第2期18-20,共3页 Journal of Chengdu University of Traditional Chinese Medicine
基金 成都中医药大学科技发展基金项目(ZRQN1555)
关键词 消异汤 子宫内膜异位症 血管内皮生长因子 大鼠 Xiaoyi tang Endometriosis Vascular Endothelial Growth Factor Rat
  • 相关文献

参考文献4

二级参考文献37

  • 1McLeod BS, Retzloff MG. Epidemiology of endometriosis: an assessment of risk factors [ J ]. Clin Obstet Gynecol, 2010, 53 (2) : 389-396.
  • 2Giudice LC. Clinical practice. Endometriosis [ J 1. N Engl J Med, 2010, 362(25): 2389-2398.
  • 3Tulandi T, Redwine D. Endometriosis: advances and controversies [ M]. New York: Informa Heahhcare,2003.
  • 4Chlenski A, Liu S, Guerrero LJ, et al. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extraeellular matrix [ J]. Int J Cancer, 2006, 118 (2) : 310-316.
  • 5Campo McKnight DA, Sosnoski DM, Koblinski JE, et al. Roles of osteonectin in the migration of breast cancer ceils into bone [ J]. J Cell Biochem, 2006, 97(2) : 288-302.
  • 6Smit D J, Gardiner BB, Sturm RA. Osteonectin downregulates E-cadherin, induces osteopontin and focal adhesion kinase activity stimulating an invasive melanoma phenotype [ J ]. Int J Cancer, 2007, 121 (12) : 2653-2660.
  • 7Hahn DW, Carraher RP, Foldesy RG, et al. Development of an animal model for quantitatively evaluating effects of drugs on endometriosis [ J ]. Fertil Steril, 1985, 44 (3) : 410-415.
  • 8Takehara M, Ueda M, Yamashita Y, et al. Vascular endothelial growth factor A and C gene expression in endometriosis [ J ]. Hum Pathol, 2004, 35(11 ): 1369-1375.
  • 9Khan KN, Masuzaki H, Fujishita A, et al. Higher activity by opaque endometriotic lesions than nonopaque lesions [ J ]. Acta Obstet Gynecol Scand, 2004, 83(4): 375-382.
  • 10Fraser HM, Lunn SF. Angiogenesis and its control in the female reproductive system [J]. Br Med Bull, 2000, 56(3) : 787-797.

共引文献24

同被引文献7

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部